Transcranial Magnetic Stimulation as a Therapeutic Option for Neurologic Diseases and Psychiatric Disorders: A Systematic Review.
neuro-modulatory
neurologic diseases
non-invasive
psychiatric disorders
transcranial magnetic stimulation
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
accepted:
22
08
2022
entrez:
26
9
2022
pubmed:
27
9
2022
medline:
27
9
2022
Statut:
epublish
Résumé
In the last two decades, transcranial magnetic stimulation (TMS) has attracted considerable interest in the research field and clinical applications because of its capacity to induce adequate electric current non-invasively for depolarizing cortex networks and superficial axons. Notably, the interest in TMS has been due to its ability to be utilized in exploring brain functioning. Indeed, reports have pointed out that TMS may effectively be used as a diagnostic and therapeutic approach for many neuropsychiatric diseases. However, they have not been sufficiently conclusive on the topic, with evidence showing mixed results. Against this backdrop, this systematic review explores TMS as a therapy option for neurologic diseases and psychiatric disorders. It summarizes and illustrates the current therapeutic uses of TMS in adults and children for detecting and treating neuropsychiatric conditions and prospective future applications. Using Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 guidelines, findings show that TMS is viable and has neuro-modulatory potential that can be employed successfully as a therapy alternative for neuropsychiatric disorders. Conversely, it is essential to more deeply understand the underlying mechanisms, alongside stimulation protocol optimization, of TMS for more practical applications.
Identifiants
pubmed: 36158376
doi: 10.7759/cureus.28259
pmc: PMC9491149
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e28259Informations de copyright
Copyright © 2022, Ozturk et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Neurol. 2022 May 20;13:793253
pubmed: 35669870
Biol Psychiatry. 2021 Nov 15;90(10):689-700
pubmed: 32800379
J Neurophysiol. 1998 Feb;79(2):1102-7
pubmed: 9463466
Headache. 2017 Mar;57(3):517-524
pubmed: 28028801
Clin Neurophysiol. 2020 Feb;131(2):474-528
pubmed: 31901449
Mov Disord. 2019 Jun;34(6):769-782
pubmed: 31034682
Cureus. 2018 Oct 16;10(10):e3456
pubmed: 30564535
Curr Neurol Neurosci Rep. 2020 Feb 4;20(1):1
pubmed: 32020300
Handb Clin Neurol. 2019;163:73-92
pubmed: 31590749
Arch Gen Psychiatry. 2010 May;67(5):507-16
pubmed: 20439832
Clin Rehabil. 2017 Mar;31(3):289-298
pubmed: 27113337
Lancet. 1985 May 11;1(8437):1106-7
pubmed: 2860322
BMJ Open. 2022 Mar 10;12(3):e051630
pubmed: 35273041
J Rehabil Med. 2022 Feb 03;54:jrm00256
pubmed: 34913062
Neurotherapeutics. 2021 Apr;18(2):827-844
pubmed: 33844154
Psychiatry Res. 2002 Oct 1;115(3):101-13
pubmed: 12208488
J Child Neurol. 2015 Aug;30(9):1111-24
pubmed: 25342309
Neuroreport. 1997 Aug 18;8(12):2787-91
pubmed: 9295118